This is the main pathway that explains that the RANK/RANKL/OPG system contributes significantly to the pathophysiological mechanism of several bone disorders by regulating osteoclastogenesis [2] and may represent the key factor for the discovery of the therapeutic properties of OPG for these diseases. The gene discussed is TNFRSF11B; the disease is bone disorder.